Interestingly, we found no impact on IAPPO-IgM or IAPPO-IgG levels in either AD patients or APOE4 carriers, suggesting a specific role for IgA in clearance of oligomeric IAPP. This evidence concerns the gene CD79A and Alzheimer disease.